GB0427603D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0427603D0
GB0427603D0 GBGB0427603.6A GB0427603A GB0427603D0 GB 0427603 D0 GB0427603 D0 GB 0427603D0 GB 0427603 A GB0427603 A GB 0427603A GB 0427603 D0 GB0427603 D0 GB 0427603D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0427603.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34090175&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0427603(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0427603.6A priority Critical patent/GB0427603D0/en
Publication of GB0427603D0 publication Critical patent/GB0427603D0/en
Priority to GT200500353A priority patent/GT200500353A/es
Priority to PL05818421T priority patent/PL1838664T3/pl
Priority to US11/721,817 priority patent/US8461385B2/en
Priority to CN2005800431247A priority patent/CN101080384B/zh
Priority to PE2005001448A priority patent/PE20060740A1/es
Priority to KR1020077013580A priority patent/KR101287233B1/ko
Priority to PCT/EP2005/013454 priority patent/WO2006063821A1/en
Priority to ARP050105245A priority patent/AR055007A1/es
Priority to BRPI0519327-3A priority patent/BRPI0519327A2/pt
Priority to CA2587213A priority patent/CA2587213C/en
Priority to RU2007126972/04A priority patent/RU2404158C2/ru
Priority to AU2005315850A priority patent/AU2005315850B2/en
Priority to EP15170908.6A priority patent/EP2955171A1/en
Priority to PT58184219T priority patent/PT1838664E/pt
Priority to ES05818421.9T priority patent/ES2547349T3/es
Priority to MX2007007211A priority patent/MX2007007211A/es
Priority to JP2007545942A priority patent/JP5224816B2/ja
Priority to EP05818421.9A priority patent/EP1838664B1/en
Priority to TW094144576A priority patent/TW200635880A/zh
Priority to ZA200703826A priority patent/ZA200703826B/xx
Priority to IL183366A priority patent/IL183366A0/en
Priority to MA29983A priority patent/MA29092B1/fr
Priority to TNP2007000229A priority patent/TNSN07229A1/fr
Priority to NO20073548A priority patent/NO338969B1/no
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0427603.6A 2004-12-16 2004-12-16 Organic compounds Ceased GB0427603D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GBGB0427603.6A GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds
GT200500353A GT200500353A (es) 2004-12-16 2005-12-02 Proceso de manufactura de compuestos organicos
JP2007545942A JP5224816B2 (ja) 2004-12-16 2005-12-14 Ｎ−置換サリチルアミドの製造法
EP05818421.9A EP1838664B1 (en) 2004-12-16 2005-12-14 Manufacture process of n-substituted salicylamides
RU2007126972/04A RU2404158C2 (ru) 2004-12-16 2005-12-14 Способ получения n-замещенных салициламидов
EP15170908.6A EP2955171A1 (en) 2004-12-16 2005-12-14 Manufacture process of n-(5-chlorosalicyloyl)-8-aminocaprylic acid
CN2005800431247A CN101080384B (zh) 2004-12-16 2005-12-14 N-取代的水杨酰胺的制备方法
PE2005001448A PE20060740A1 (es) 2004-12-16 2005-12-14 Proceso de fabricacion de derivados de salicilamidas n-sustituidas
KR1020077013580A KR101287233B1 (ko) 2004-12-16 2005-12-14 Ｎ-치환된 살리실아미드의 제조 방법
PCT/EP2005/013454 WO2006063821A1 (en) 2004-12-16 2005-12-14 Manufacture process of n-substituted salicylamides
ARP050105245A AR055007A1 (es) 2004-12-16 2005-12-14 Proceso de fabricacion de salicilamidas n-sustituidas
BRPI0519327-3A BRPI0519327A2 (pt) 2004-12-16 2005-12-14 processo de preparaÇço de salicilamida n-substituÍda, composto, uso do mesmo e composiÇço farmacÊutica
CA2587213A CA2587213C (en) 2004-12-16 2005-12-14 Manufacture process of n-substituted salicylamides
PL05818421T PL1838664T3 (pl) 2004-12-16 2005-12-14 Sposób wytwarzania N-podstawionych salicylamidów
AU2005315850A AU2005315850B2 (en) 2004-12-16 2005-12-14 Manufacture process of N-substituted salicylamides
US11/721,817 US8461385B2 (en) 2004-12-16 2005-12-14 Manufacture process of organic compounds
PT58184219T PT1838664E (pt) 2004-12-16 2005-12-14 Processo de fabrico de salicilamidas n-substituídas
ES05818421.9T ES2547349T3 (es) 2004-12-16 2005-12-14 Proceso de fabricación de salicilamidas N-sustituidas
MX2007007211A MX2007007211A (es) 2004-12-16 2005-12-14 Procedimiento de fabricacion de salicilamidas n-sustituidas.
TW094144576A TW200635880A (en) 2004-12-16 2005-12-15 Manufacture process of organic compounds
ZA200703826A ZA200703826B (en) 2004-12-16 2007-05-11 Manufacture process of N-substituted salicylamides
IL183366A IL183366A0 (en) 2004-12-16 2007-05-21 Manufacture process of n-substituted salicylamides
MA29983A MA29092B1 (fr) 2004-12-16 2007-06-11 Procédé de synthèse de salicylamides n-substitués
TNP2007000229A TNSN07229A1 (en) 2004-12-16 2007-06-15 Manufacture process of n-substituted salicylamides
NO20073548A NO338969B1 (no) 2004-12-16 2007-07-09 Fremgangsmåte for fremstilling av N-substituerte salisylamider

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0427603.6A GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds

Publications (1)

Publication Number Publication Date
GB0427603D0 true GB0427603D0 (en) 2005-01-19

Family

ID=34090175

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0427603.6A Ceased GB0427603D0 (en) 2004-12-16 2004-12-16 Organic compounds

Country Status (24)

Country Link
US (1) US8461385B2 (enExample)
EP (2) EP1838664B1 (enExample)
JP (1) JP5224816B2 (enExample)
KR (1) KR101287233B1 (enExample)
CN (1) CN101080384B (enExample)
AR (1) AR055007A1 (enExample)
AU (1) AU2005315850B2 (enExample)
BR (1) BRPI0519327A2 (enExample)
CA (1) CA2587213C (enExample)
ES (1) ES2547349T3 (enExample)
GB (1) GB0427603D0 (enExample)
GT (1) GT200500353A (enExample)
IL (1) IL183366A0 (enExample)
MA (1) MA29092B1 (enExample)
MX (1) MX2007007211A (enExample)
NO (1) NO338969B1 (enExample)
PE (1) PE20060740A1 (enExample)
PL (1) PL1838664T3 (enExample)
PT (1) PT1838664E (enExample)
RU (1) RU2404158C2 (enExample)
TN (1) TNSN07229A1 (enExample)
TW (1) TW200635880A (enExample)
WO (1) WO2006063821A1 (enExample)
ZA (1) ZA200703826B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101627011A (zh) 2005-09-19 2010-01-13 爱密斯菲尔科技公司 N-(5-氯水杨酰基)-8-氨基辛酸的二钠盐的晶形
PL2215047T3 (pl) 2007-11-02 2014-05-30 Emisphere Tech Inc Sposób leczenia niedoborów witaminy b12
CN109473182B (zh) * 2018-11-12 2021-10-19 北京北排科技有限公司 一种基于深度信念网络的mbr膜透水率智能检测方法
CA3141383A1 (en) * 2019-05-20 2020-11-26 Lonza Guangzhou Pharmaceutical Ltd. Method for preparation of carsalam
CN115260116B (zh) * 2022-08-19 2024-04-12 株洲壹诺生物技术有限公司 8-(2-羟基苯甲酰胺基)辛酸钠及苯并噁嗪-2,4-二酮和8-溴辛酸乙酯的制法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU382610A1 (ru) * 1968-07-08 1973-05-25 Способ получения амидов карбоновых кислот
DE60017888T2 (de) 1999-04-05 2006-01-19 Emisphere Technologies, Inc. Dinatrium-salze, monohydrate und ethanol-solvate
TR200200619T2 (tr) * 1999-06-25 2003-01-21 The Institutes For Pharmaceutical Discovery, Llc. İkame edilmiş fenoksiasetik asitler.
ES2386263T3 (es) 2000-03-21 2012-08-14 Emisphere Technologies, Inc. Método de preparación de salicilamidas alquiladas mediante un producto intermedio de dicarboxilato
US7262325B2 (en) 2000-06-02 2007-08-28 Emisphere Technologies, Inc. Method of preparing salicylamides
WO2003057650A2 (en) * 2002-01-09 2003-07-17 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
EP1299348B1 (en) * 2000-06-29 2008-04-09 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US7495030B2 (en) * 2000-09-06 2009-02-24 Emisphere Technologies, Inc. (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
US7049283B2 (en) * 2000-12-06 2006-05-23 Novartis Ag Pharmaceutical compositions for the oral delivery of pharmacologically active agents
JP4417113B2 (ja) * 2002-02-20 2010-02-17 エミスフェアー・テクノロジーズ・インク Ｇｌｐ−１分子の投与方法
US20050054557A1 (en) * 2002-05-09 2005-03-10 Goldberg Michael M. Compositions for delivering parathyroid hormone and calcitonin

Also Published As

Publication number Publication date
PL1838664T3 (pl) 2016-04-29
CN101080384B (zh) 2011-06-15
NO338969B1 (no) 2016-11-07
AR055007A1 (es) 2007-08-01
NO20073548L (no) 2007-09-17
BRPI0519327A2 (pt) 2009-01-13
TNSN07229A1 (en) 2008-11-21
IL183366A0 (en) 2007-09-20
RU2404158C2 (ru) 2010-11-20
CN101080384A (zh) 2007-11-28
JP5224816B2 (ja) 2013-07-03
JP2008524142A (ja) 2008-07-10
EP2955171A1 (en) 2015-12-16
GT200500353A (es) 2006-07-17
MX2007007211A (es) 2007-08-15
RU2007126972A (ru) 2009-01-27
EP1838664B1 (en) 2015-07-15
TW200635880A (en) 2006-10-16
ES2547349T3 (es) 2015-10-05
ZA200703826B (en) 2008-08-27
US20090253811A1 (en) 2009-10-08
MA29092B1 (fr) 2007-12-03
AU2005315850A1 (en) 2006-06-22
KR20070086276A (ko) 2007-08-27
PE20060740A1 (es) 2006-09-04
CA2587213A1 (en) 2006-06-22
PT1838664E (pt) 2015-10-16
US8461385B2 (en) 2013-06-11
EP1838664A1 (en) 2007-10-03
WO2006063821A1 (en) 2006-06-22
AU2005315850B2 (en) 2009-11-05
KR101287233B1 (ko) 2013-07-17
CA2587213C (en) 2015-05-19

Similar Documents

Publication Publication Date Title
GB0410712D0 (en) Organic compounds
GB0409921D0 (en) Organic compounds
GB0403038D0 (en) Organic compounds
GB0407723D0 (en) Organic compounds
GB0404434D0 (en) Organic compounds
GB0405289D0 (en) Organic compounds
GB0401334D0 (en) Organic compounds
GB0402797D0 (en) Organic compounds
GB0408078D0 (en) Organic compounds
GB0400781D0 (en) Organic compounds
GB0403115D0 (en) Organic compounds
GB0406515D0 (en) Organic compounds
GB0403254D0 (en) Organic compounds
GB0405723D0 (en) Organic compounds
GB0409236D0 (en) Organic compounds
GB0406240D0 (en) Organic compounds
GB0405898D0 (en) Organic compounds
GB0407468D0 (en) Organic compounds
GB0405034D0 (en) Organic compounds
GB0407607D0 (en) Organic compounds
GB0405900D0 (en) Organic compounds
GB0407466D0 (en) Organic compounds
GB0403964D0 (en) Organic compounds
GB0402682D0 (en) Organic compounds
GB0427230D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)